Bone And Joint Health Ingredient Market Global Research Report Forecast till 2027

Bone And Joint Health Ingredient Market Global Research Report Forecast till 2027

Market Overview

The market for bone and joint health ingredients is anticipated to grow at a 7.69% CAGR and reach USD 28,481.78 million in value by 2027. The increasing prevalence of bone and joint disorders and the rising demand for bone and joint health ingredients among the elderly population in functional foods, beverages, and dietary supplements are both factors contributing to the growth of the global market for bone and joint health ingredients. However, growing consumer knowledge of the negative consequences of goods containing ingredients for bone and joint health could slow market expansion. Additionally, the developing markets for ingredients that promote bone and joint health present potential chances for market expansion in the future.

The market is anticipated to expand because of the rising demand for bone and joint health elements in functional food, beverages, and dietary supplements, rising demand from the older population, and the rising prevalence of orthopedic illnesses. However, concerns including adverse reactions to the components for bones and joints and strict government regulations are anticipated to impede market expansion. However, it is anticipated that untapped markets in developing nations, development strategies by important companies, the influence of social media, and creative marketing techniques will lead to profitable expansion.

Segment Overview

The market for ingredients for bone and joint health has been divided into categories based on type, including calcium, collagen, glucosamine, chondroitin, magnesium, and vitamins.

The global market for bone and joint health ingredients has been divided into three application groups: pharmaceuticals, food and beverage, and nutraceuticals & dietary supplements. In 2020, the Nutraceuticals & Dietary Supplements segment held a higher market share of 65.55%, and it is anticipated to experience the greatest CAGR of 8.60% during the following five years.

Regional Analysis

By area, the worldwide Bone and joint health ingredient market have been partitioned into North America, Europe, Asia-Pacific, and the Remainder of the World.

Asia-Pacific is projected to expand at a 8.20% most noteworthy CAGR during the figure time frame. Asia-Pacific is expected to enlist the most noteworthy development rate over the gauge period from this is because of the great frequency of joint pain and osteoporosis, further developing healthcare, expanding per capita extra cash, and expanding bone and joint health mindfulness. Numerous grown-ups dwelling in the district are supposed to experience the ill effects of different muscular problems.

Europe represented the second-biggest market portion of 28.80% of the Bone and joint health ingredient market in 2020. The local market is supposed to enroll a CAGR of 7.07% during the estimate time frame. Europe is expected to observe critical development over the gauge period because of a bigger number of patients experiencing bone and joint-related messes, the accessibility of items in the district, and the developing geriatric populace. The quantity of hip and knee substitution methods has expanded quickly in most OECD nations.

Major Players

Prominent players in the global Bone and joint health ingredient market include DSM (Netherlands), Stratum Nutrition (US), BASF SE (Germany), Archer-Daniels-Midland Company (ADM) (US), s (Ireland), Holista Colltech (Australia), Lonza Group (Switzerland), PharmaZen Limited (New Zealand), Darling Ingredients (US), Bioiberica S.A.U. (Spain).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.Companies Mentioned

DSM (Netherlands)
Stratum Nutrition (US)
BASF SE (Germany)
Archer-Daniels-Midland Company (ADM) (US)
s (Ireland)
Holista Colltech (Australia)
Lonza Group (Switzerland)
PharmaZen Limited (New Zealand)
Darling Ingredients (US)
Bioiberica S.A.U. (Spain)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.